DCF — RIPON MEDICAL CENTER
Enterprise Value: $-8.4M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-8.4M
Enterprise Value
$-3.6M
PV of Cash Flows
$-4.8M
PV of Terminal Value
$-7.8M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $34.0M | $0.0M | 0.0% | $-1.4M | $-1.3M |
| Year 2 | $35.0M | $0.4M | 1.0% | $-1.1M | $-0.9M |
| Year 3 | $36.1M | $0.7M | 2.0% | $-0.8M | $-0.6M |
| Year 4 | $37.2M | $1.0M | 3.0% | $-0.6M | $-0.4M |
| Year 5 | $38.3M | $1.1M | 3.0% | $-0.6M | $-0.4M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-8.4M. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$33.0M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.004293084886278886
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5